EP2785349
Samsett meðhöndlun á krabbameini
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
30.11.2012EP published:
16.10.2019EP application number:
12795842.9
EP translation filed:
11.12.2019Grant published:
15.1.2020EPO information:
European Patent Register
Max expiry date:
29.11.2032Expiry date:
29.11.2026Next due date:
30.11.2026
Title:
COMBINATION TREATMENT OF CANCER
Timeline
Today
30.11.2012EP application
16.10.2019EP Publication
11.12.2019Translation submitted
15.1.2020Registration published
29.11.2026Expires
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
DAVIES, Barry, RobertAddress:
MacclesfieldCheshire SK10 4TG, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161564975 PDate:
30.11.2011Country:
US
Classification
Categories:
A61K 31/519, A61P 35/00, A61K 31/277, A61K 31/4166, A61K 31/58, A61K 31/5025, A61P 13/08
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 29.11.2019
Expires: 29.11.2020
Payer: Árnason Faktor
Number: 9
Paid: 6.10.2020
Expires: 29.11.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.10.2021
Expires: 29.11.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 6.10.2022
Expires: 29.11.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 9.11.2023
Expires: 29.11.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 9.11.2023
Expires: 29.11.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 8.10.2024
Expires: 29.11.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 17.11.2025
Expires: 29.11.2026
Payer: Árnason Faktor ehf.